-
Apyx Medical Corp. (APYX) Tops Q4 EPS by 6c ; Offers Guidance
-
Apyx Medical reports 34% revenue growth in fourth quarter 2025
-
Roth/MKM Starts Apyx Medical Corp. (APYX) at Buy
-
APYX Medical launches cosmetic surgery devices in South Korea
-
Apyx Medical Corp. (APYX) files $100M mixed shelf
-
Citizens Upgrades Apyx Medical Corp. (APYX) to Market Outperform
-
Apyx Medical Corp. (APYX) Tops Q3 EPS by 5c ; Offers Guidance
-
Citizens Says Apyx Medical Corp. (APYX) Can Be Preferred Partner For Aesthetic Treatments
-
Lucid Capital Markets Starts Apyx Medical Corp. (APYX) at Buy
-
Citizens JMP Reiterates Market Perform Rating on Apyx Medical Corp. (APYX)
-
Apyx Medical Corp. (APYX) Tops Q2 EPS by 18c
-
Apyx Medical hires two sales executives for global expansion
-
Apyx Medical launches Renuvion device in China through distributor deal
-
Apyx Medical Corp. (APYX) Receives FDA Clearance for the AYON Body Contouring System
-
Apyx Medical Corp. (APYX) Tops Q1 EPS by 2c ; Offers Guidance
-
Citizens JMP Reiterates Market Perform Rating on Apyx Medical Corp. (APYX)
-
Apyx Medical Corp. (APYX) Tops Q4 EPS by 4c ; Offers Guidance
-
Apyx Medical Corp. (APYX) Submits FDA 510(k) Premarket Notification for AYON Body Contouring System
-
Apyx Medical Corp. (APYX) Announces $7,000,000 Million Registered Direct Offering
-
Apyx Medical Corp. (APYX) Tops Q3 EPS by 4c ; Offers Guidance
-
BTIG Starts Apyx Medical Corp. (APYX) at Neutral

